(Total Views: 690)
Posted On: 04/17/2020 12:58:05 PM
Post# of 148984
Best thing I've heard so far is Dr. Lalezari saying source of frustration to them as well is JAMA not listing a few days ago LERONLIMAB among treatments. He said Dr. Patterson's idea to use Leron for Covid-19 is BRILLIANT... and when the data is pulled together, the entire world will get it!!! (everybody will get it in a couple of weeks).
No chance Covid is ending any time soon... until there's vaccine treatment... thinks CytoDyn has that treatment and will be a key piece to the world.
As a non-sh, Lalezari is giving his professional opinion...
Dr. Bruces basically saying Leronlimab fights it all... an immunologic disease causing all the morbidity. All patients on Leronlimab are improving (mho, no failures to date). Will be looking at Leron for influenza, information is very very exciting. What learned from Covid is giving additional indications because of broad effects seeing on immune system.
Remdesivir doesn't compare to Leronlimab... all others are just targetting one thing or another (PIECEMEAL)... unlike Leronlimab which is correcting deficiencies across spectrum of disease (covid)... now being supported by clinical evidence!!
Side note. Dr. Pourhassan excited about hearing back from United Kingdom next week about data submitted to them.
He's informed all will be filing BLA next week...
Samsung has agreed to deliver 1.2-million viles this year... Dr. Kim of Samsung also said if you need more product we can make as much as you want - can produce up to 3mm viles in (not sure if he said month or months).
Have 300 questions come in...
No chance Covid is ending any time soon... until there's vaccine treatment... thinks CytoDyn has that treatment and will be a key piece to the world.
As a non-sh, Lalezari is giving his professional opinion...
Dr. Bruces basically saying Leronlimab fights it all... an immunologic disease causing all the morbidity. All patients on Leronlimab are improving (mho, no failures to date). Will be looking at Leron for influenza, information is very very exciting. What learned from Covid is giving additional indications because of broad effects seeing on immune system.
Remdesivir doesn't compare to Leronlimab... all others are just targetting one thing or another (PIECEMEAL)... unlike Leronlimab which is correcting deficiencies across spectrum of disease (covid)... now being supported by clinical evidence!!
Side note. Dr. Pourhassan excited about hearing back from United Kingdom next week about data submitted to them.
He's informed all will be filing BLA next week...
Samsung has agreed to deliver 1.2-million viles this year... Dr. Kim of Samsung also said if you need more product we can make as much as you want - can produce up to 3mm viles in (not sure if he said month or months).
Have 300 questions come in...
(2)
(0)Scroll down for more posts ▼
